Dipeptidyl Peptidase IV Inhibitory Activity of Berberine and Mangiferin: An In Silico Approach
<p><strong>Background:</strong> Dipeptidyl peptidase-IV (DDP-IV) Inhibitors may represent single anti-diabetic drugs, the multiple actions of which may translate into demonstrable therapeutic benefits in diabetes. The marketed synthetic DPP-IV Inhibitors are expensive drugs and h...
Saved in:
Main Authors: | Ipseeta Ray Mohanty (Author), Selvaa Kumar (Author), Rajesh Suman (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications,
2017-07-08.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Analysis of novel Phytocompounds targetting Dipeptidyl peptidase 4 Enzyme: A New Link between Prediabetes and its cardio-metabolic complications
by: Ipseeta Ray Mohanty, et al.
Published: (2024) -
Dipeptidyl peptidase IV inhibitors derived from a mangrove flora Rhizophora mucronata: An in silico approach
by: Selvaraj Gurudeeban, et al.
Published: (2012) -
New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
by: Chenkai Cui, et al.
Published: (2022) -
α-Amylase and dipeptidyl peptidase-4 (DPP-4) inhibitory effects of Melicope latifolia bark extracts and identification of bioactive constituents using in vitro and in silico approaches
by: Alexandra Quek, et al.
Published: (2021) -
Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV
by: Rohani, et al.
Published: (2023)